Phytopharmaceuticals are basically plant-based drugs, but developed in a more scientific way than the usual herbal products we see in the market. Instead of using the whole plant or a simple extract, these medicines are processed, purified, and tested properly so that the active parts are known and consistent.
Phytopharmaceuticals sit between traditional knowledge and modern drug development — but the regulatory pathway is fully CDSCO-driven. Anyone planning to develop or register these products in India needs to understand this distinction clearly.
What Is Phytopharmaceuticals?
A phytopharmaceutical is still plant-based, but it’s not the usual herbal type product. It’s not just about taking a plant extract and using it directly — the useful part is identified and kept consistent across batches. That’s why they’re treated differently from regular herbal products and seen closer to drug-type products.
According to Drugs and Cosmetics Rules (8th Amendment), 2015, a Phytopharmaceutical Drug is defined as:
- A purified and standardized fraction of a plant or its part/extract.
- Administered as medicine for specific therapeutic claims.
- Contains active phytochemicals in a standardized form.
- Not a traditional or herbal medicine unless processed into a more defined form.
Regulatory Agency For Phytopharmaceuticals In India
Phytopharmaceuticals don’t come under AYUSH like regular herbal or Ayurveda products. In India, they are handled by CDSCO, since they are treated more like drugs than traditional formulations. Because of that, the kind of data expected is also different.
Companies usually have to submit details around the plant source, how the extract is prepared, how it’s standardized, along with safety and clinical data. Once everything is submitted, the application goes through review, and approval is issued through the DCGI
Explore reliable Pharma Regulatory Affairs Services in India to accelerate your approvals.
Phytopharmaceutical Regulations in India
- Phytopharmaceuticals are treated under the new drug category, so the expectations are closer to pharma than herbal products.
- The product needs to be based on a defined plant extract or fraction, not a crude or traditional mixture.
- Details around the plant source, part used, and extraction process are usually part of the submission.
- Some level of standardisation is usually needed so the main active parts don’t keep changing from one batch to another.
- Data around safety and how the product works is generally looked at, and in a lot of cases this goes beyond just basic studies.
- On the manufacturing side, processes are expected to be controlled well enough to avoid mix-ups or quality issues during production.
- Products are reviewed by CDSCO, not under the AYUSH route used for traditional medicines.
After approval, companies are still expected to monitor safety and report issues, similar to other pharma products.
Phytopharmaceuticals Registration Process In India:
There isn’t just one single step when it comes to getting a phytopharmaceutical approved in India. It tends to move in stages, and a lot depends on how ready the data is. Here is how the registration process of Phytopharmaceuticals in India usually works:
- Step 1: Deciding the product category
At the start, this is where things usually get a bit unclear. Some products don’t sit neatly in one bucket, especially when they look close to herbal or Ayurveda. So this part often gets sorted first, otherwise it tends to cause back-and-forth later. - Step 2: Preparing the data and dossier
Most of the time goes here. Companies need to pull together details about the plant source, how the extract is prepared, and how consistency is maintained. Along with that, safety data and whatever study results are available also go into the file. - Step 3: Generating study data (if required)
What’s submitted initially doesn’t always cover everything. After a point, there can be questions or missing pieces. When that happens, more data or studies are brought in before things move ahead. - Step 4: Submission to CDSCO
Once the documents are more or less in place, the application is submitted to CDSCO. This is typically done online, along with all the supporting details that have been prepared up to that point. - Step 5: Review and queries
After submission, the file is reviewed. It’s quite common to receive queries or requests for clarification, especially around quality or study data. This part can take time depending on how quickly responses are provided. - Step 6: Approval from DCGI
If everything is in place and the responses are accepted, the approval is issued. Only after this can the product be marketed.
Also Read: CDSCO Pharmaceutical Regulations in India
GMP Requirements for Phytopharmaceuticals in India
When it comes to GMP, the expectations are quite similar to other pharma products, but with added attention to how plant materials behave during processing.
- Facilities and setup
The layout usually needs to be thought through in a way that avoids overlap between stages. Handling raw plant material, extraction, and final packing don’t typically happen in the same space. Even basic things like airflow and dust control matter more here, especially when powders are involved. - Equipment side
Most setups rely on non-reactive equipment — stainless steel is commonly used. What matters more in practice is how well the equipment is maintained over time, since residue from plant extracts can affect consistency if not handled properly. - Raw material handling
A lot depends on where the plant material comes from. Companies generally keep records around the source, type of plant, and how it was grown or collected. Storage also plays a role, because plant material can degrade if conditions aren’t stable. Before use, checks around identity and contamination are usually part of the routine. - Quality and consistency
With plant extracts, one batch can easily turn out a bit different from another if things aren’t controlled properly. So most of the attention goes into keeping the key components steady and checking that nothing unusual shows up in the final product over time.
Also Read: SUGAM For Regulatory Submissions
Phytopharmaceuticals Clinical trials & Post-approval
For trials, there’s usually an ethics review involved before anything begins. In parallel, the study details tend to get listed on CTRI so it’s on record.
After the product is out in the market, companies don’t just leave it there. They keep an eye on how it’s being used and step in if any safety-related issues show up.
Phytopharmaceuticals Labeling Requirements in India
Labels are expected to give a fair idea of what’s inside and how the product is meant to be used. That includes the plant source and what part of it is actually standardised.
Basic usage details, along with any precautions and storage instructions, are typically included so there’s no guesswork at the user’s end.
Fees For Phytopharmaceuticals Application:
On the cost side, there are fixed government fees for both import and manufacturing permissions, and they are usually in the same range per product.
Clinical trial fees are separate and vary depending on the phase involved, so that part tends to differ case by case. For a clearer estimate on overall costs and support through the full phytopharmaceutical registration process, you can reach out to our team at info@artixio.com
Conclusion
Phytopharmaceuticals in India sit somewhere between traditional plant use and modern drug development. The regulations reflect that balance, asking for proper data while still working with plant-based sources.
So anyone planning to enter this space needs to approach it with that mindset from the beginning.
If you’re working on a phytopharmaceutical registration and compliance in India and need some clarity on the process, you can write to info@artixio.com
FAQs:
How are the phytopharmaceuticals different from herbal or Ayurveda products?
They may both come from plants, but the approach is quite different.
- Phytopharmaceuticals are developed in a more controlled way, where the key components are identified and managed.
- Herbal or Ayurveda products are more traditional in how they’re made and used, without going into that level of detail.
Who handles approvals for phytopharmaceuticals?
in India, CDSCO does the phytopharmaceuticals approvals. They treat these products like new drugs.
Do phytopharmaceuticals require clinical trials like regular drugs?
In many cases, yes. Since they fall under CDSCO, there is an expectation to support claims with clinical or human data.
Herbal or Ayurveda products, on the other hand, may rely more on traditional use and existing literature instead of full clinical trials.
